DaVita (NYSE:DVA – Get Free Report) posted its earnings results on Thursday. The company reported $2.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.95 by $0.43, RTT News reports. DaVita had a return on equity of 64.42% and a net margin of 5.70%. The firm had revenue of $3.07 billion for the quarter, compared to analyst estimates of $3.03 billion. During the same quarter in the prior year, the company earned $1.58 EPS. DaVita’s revenue was up 6.9% on a year-over-year basis. DaVita updated its FY24 guidance to $9.00-$9.80 EPS.
DaVita Stock Up 1.8 %
Shares of DVA traded up $2.46 during mid-day trading on Thursday, reaching $142.21. The company’s stock had a trading volume of 1,891,441 shares, compared to its average volume of 819,306. DaVita has a 12-month low of $71.51 and a 12-month high of $143.23. The stock has a market cap of $12.47 billion, a PE ratio of 18.89, a price-to-earnings-growth ratio of 1.24 and a beta of 1.04. The company has a debt-to-equity ratio of 6.65, a current ratio of 1.19 and a quick ratio of 1.13. The company’s 50 day moving average is $133.13 and its 200 day moving average is $111.96.
Insider Activity
In other news, insider James O. Hearty sold 26,164 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $119.64, for a total value of $3,130,260.96. Following the transaction, the insider now owns 20,264 shares in the company, valued at approximately $2,424,384.96. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, CEO Javier Rodriguez sold 67,603 shares of the firm’s stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the transaction, the chief executive officer now owns 488,697 shares in the company, valued at approximately $61,629,578.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider James O. Hearty sold 26,164 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $119.64, for a total value of $3,130,260.96. Following the transaction, the insider now owns 20,264 shares in the company, valued at approximately $2,424,384.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 134,540 shares of company stock worth $16,551,071. 1.40% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on DVA
DaVita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Articles
- Five stocks we like better than DaVita
- Using the MarketBeat Dividend Tax Calculator
- Meta Stock: 3 Reasons This Stumble Is a Golden Buying Opportunity
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Staples Stocks to Cushion Lower Consumer Sentiment
- How to Start Investing in Real Estate
- Zillow’s Earnings Dip: An Opportunity for Visionaries
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.